BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31447009)

  • 21. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer.
    Hayman JA; Abrahamse PH; Lakhani I; Earle CC; Katz SJ
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1001-7. PubMed ID: 17689029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy for brain metastases near the end of life in an integrated health care system.
    Ryoo JJ; Batech M; Zheng C; Kim RW; Gould MK; Kagan AR; Lien WW
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S28-S38. PubMed ID: 28595434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
    Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palliative radiotherapy for advanced Cancer: Are we giving it to the right patient at the right time?
    Syadwa AS; Anita ZB
    Med J Malaysia; 2018 Aug; 73(4):190-196. PubMed ID: 30121680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care.
    Ning MS; Das P; Rosenthal DI; Dabaja BS; Liao Z; Chang JY; Gomez DR; Klopp AH; Gunn GB; Allen PK; Nitsch PL; Natter RB; Briere TM; Herman JM; Wells R; Koong AC; McAleer MF
    J Natl Compr Canc Netw; 2021 Apr; 19(7):805-813. PubMed ID: 33878727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer.
    Swaminath A; Wright JR; Tsakiridis TK; Ung YC; Pond GR; Sur R; Corbett TB; Okawara G; Levine MN
    Clin Lung Cancer; 2016 Mar; 17(2):142-9. PubMed ID: 26521036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Provider decision regret-a useful method for analysis of palliative thoracic re-irradiation for lung cancer?
    Nieder C; Mannsåker B; Yobuta R; Haukland E
    Strahlenther Onkol; 2020 Apr; 196(4):315-324. PubMed ID: 32002566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer.
    McDermott RL; Armstrong JG; Thirion P; Dunne M; Finn M; Small C; Byrne M; O'Shea C; O'Sullivan L; Shannon A; Kelly E; Hacking DJ
    Radiother Oncol; 2018 May; 127(2):253-258. PubMed ID: 29548561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison.
    Nieder C; Dalhaug A; Pawinski A; Haukland E; Mannsåker B; Engljähringer K
    Radiat Oncol; 2015 Mar; 10():61. PubMed ID: 25889414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study.
    Lupattelli M; Maranzano E; Bellavita R; Chionne F; Darwish S; Piro F; Latini P
    Am J Clin Oncol; 2000 Feb; 23(1):89-93. PubMed ID: 10683087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
    Br J Cancer; 1991 Feb; 63(2):265-70. PubMed ID: 1705140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial.
    Planting A; Helle P; Drings P; Dalesio O; Kirkpatrick A; McVie G; Giaccone G
    Ann Oncol; 1996 Feb; 7(2):139-44. PubMed ID: 8777169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.
    Nieder C; Tollåli T; Haukland E; Reigstad A; Flatøy LR; Dalhaug A
    Clin Lung Cancer; 2017 Jul; 18(4):e297-e301. PubMed ID: 28189593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palliative radiotherapy regimens for non-small cell lung cancer.
    Macbeth F; Toy E; Coles B; Melville A; Eastwood A
    Cochrane Database Syst Rev; 2001; (3):CD002143. PubMed ID: 11687016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palliative radiotherapy regimens for non-small cell lung cancer.
    Macbeth F; Toy E; Coles B; Melville A; Eastwood A
    Cochrane Database Syst Rev; 2001; (2):CD002143. PubMed ID: 11406035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy in palliation of thoracic tumors: a phase I-II study (SHARON project).
    Farina E; Macchia G; Buwenge M; Siepe G; Zamagni A; Cammelli S; Cilla S; Wondemagegnhu T; Woldemariam AA; Uddin AFMK; Sumon MA; Cellini F; Deodato F; Morganti AG
    Clin Exp Metastasis; 2018 Dec; 35(8):739-746. PubMed ID: 30298381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.
    Werner-Wasik M; Pequignot E; Leeper D; Hauck W; Curran W
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):689-96. PubMed ID: 11020565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of palliative radiotherapy in locally advanced non-small cell lung cancer.
    Cetingoz R; Kentli S; Uruk O; Demirtas E; Sen M; Kinay M
    Neoplasma; 2001; 48(6):506-10. PubMed ID: 11949846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.